SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
BACKGROUND: SLC/CCL21, normally expressed in high endothelial venules and in T cell zones of spleen and lymph nodes, strongly attracts T cells and dendritic cells (DC). We have previously shown that SLC/CCL21-mediated anti-tumor responses are accompanied by significant induction of IFNγ and the CXC...
Na minha lista:
| Udgivet i: | Mol Cancer |
|---|---|
| Principais autores: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2003
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC155639/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12740040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-4598-2-22 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
